Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Zhongshan Ophthalmic Center, Sun Yat-sen University appears in 34 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
34 shownHome- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCTNCT06610747 · lead sponsor · 2024-10-28
RECRUITINGChoroidal and Retinal Features in PACD and POAG on OCT and OCTANCT07580014 · lead sponsor · 2024-07-16
RECRUITINGComparison of Cytokines Profile in Aqueous Humor and Tear Before and After UCP TreatmentNCT06243497 · lead sponsor · 2024-02-01
RECRUITINGBiometric Changes After Intervention of Anterior Chamber Angle : an Observational StudyNCT06492538 · lead sponsor · 2023-12-01
RECRUITINGMultimodal Biomarkers in Prediction of Diabetic RetinopathyNCT07098832 · lead sponsor · 2025-07-01
NOT_YET_RECRUITINGResearch on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular DiseasesNCT07003165 · lead sponsor · 2025-07-01
NOT_YET_RECRUITINGAn Interpretable Fundus Diseases Report Generating System Based On Weakly LabelingsNCT06918028 · lead sponsor · 2025-05-01
NOT_YET_RECRUITINGEffects of Primary Open-angle Glaucoma on Visual-motor CoordinationNCT06692205 · lead sponsor · 2024-11-21
UNKNOWNExploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory DamageNCT06272565 · lead sponsor · 2024-07-03
NOT_YET_RECRUITINGEvaluation of Visual Training System in Patients With GlaucomaNCT06433102 · lead sponsor · 2024-06-03
UNKNOWNLiwan Eye Study: the Fourth Follow-upNCT06333470 · lead sponsor · 2024-03-30
UNKNOWNEvaluation of New Head-mounted Visual Aids Among Patients With Low VisionNCT06076720 · lead sponsor · 2023-10-10
UNKNOWNEffect of Peripapillary Atrophy to Diagnose Glaucoma in High MyopiaNCT05964634 · lead sponsor · 2023-08-01
UNKNOWNThe Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's DiseaseNCT04277767 · lead sponsor · 2022-09-01
UNKNOWNEffect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle GlaucomaNCT05309811 · lead sponsor · 2022-04-01
UNKNOWNHome Monitoring of Diabetic Macular EdemaNCT05223569 · lead sponsor · 2022-03-03
UNKNOWNSelf-testing Diagnosis Imaging Model for Diabetic RetinopathyNCT05223556 · lead sponsor · 2022-02-01
COMPLETEDMacular Pigment Optical Density in Primary Angle-closure DiseaseNCT05251792 · lead sponsor · 2021-11-11
UNKNOWNXEN45 in the Treatment of Chinese Patients With Primary Open-angle GlaucomaNCT05130554 · lead sponsor · 2021-11-07
UNKNOWNPars Plana Vitrectomy Combined With Phacoemulsification Cataract Surgery in Phakic Diabetes Retinopathy PatientsNCT04729023 · lead sponsor · 2021-02-01
COMPLETEDEffects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)NCT04627402 · lead sponsor · 2020-11-12
UNKNOWNDevelopment of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric PropertiesNCT04722861 · lead sponsor · 2020-09-08
UNKNOWNEvaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTANCT04515017 · lead sponsor · 2020-09-01
UNKNOWNA Trial on Ophthalmologist-delivered Health Education on Top of Routine Community CareNCT04490941 · lead sponsor · 2020-07-22
UNKNOWNPredicting the Effect of Laser Peripheral IridotomyNCT04495491 · lead sponsor · 2020-07-01
UNKNOWNEffect of Metformin on Visual Function in Patients With GlaucomaNCT04155164 · lead sponsor · 2019-12-10
UNKNOWNStudy on Intraocular Structural Parameters and Surgical Effect Before and After the Onset of Malignant GlaucomaNCT04220879 · lead sponsor · 2019-11-25
UNKNOWNUCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle GlaucomaNCT04321122 · lead sponsor · 2018-08-12
UNKNOWNMulti-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical ApplicationNCT03899623 · lead sponsor · 2018-04-23
UNKNOWNComparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients InpatientsNCT03125850 · lead sponsor · 2017-08-10
COMPLETEDEffect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis SyndromeNCT04334564 · lead sponsor · 2015-04-28
UNKNOWNDeep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)NCT04003558 · collaborator · 2019-05-28
UNKNOWNA Multi-center Study on the Artificial Intelligence Enabled Diabetic Retinopathy Screening Based on Fundus ImagesNCT03602989 · collaborator · 2018-07-05
UNKNOWNAhmed Glaucoma Valve Surgery With Mitomycin-CNCT02805257 · collaborator · 2016-06-01
COMPLETEDDrugs studied in this sponsor's trials
3 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Zhongshan Ophthalmic Center, Sun Yat-sen University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
0.05 ML aflibercept 40 MG/ML Injection1
metformin1
mitomycin1
0.05 ML aflibercept 40 MG/ML Injection RxCUI 1232154 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
mitomycin RxCUI 632 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor31
collaborator3
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.